Literature DB >> 1356282

HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers.

M Ota1, T Seki, H Fukushima, K Tsuji, H Inoko.   

Abstract

We previously introduced HLA-DQA1, -DPB1 and DQB1 genotyping with the modified PCR-RFLP method using some informative restriction enzymes which have either a single cleavage site or alternatively no cleavage site in the amplified DNA region, depending on the HLA alleles, making reading of RFLP band patterns much easier. In this study, 43 HLA-DRB1 alleles, excluding DRB1*1103 and *1104 for which no restriction enzymes are available to distinguish each from the other, could be defined by this modified PCR-RFLP method combined with 7 pairs of group-specific primers. It is impossible to distinguish DRB1*0701 and DRB1*0702 as they are identical for the second exon of DRB1. For DR1-DRB1, DR2-DRB1, DR4-DRB1, DR7-DR1, DR9-DRB1, DRw10-DRB1 or DRw52 associated antigens (DR3, w11, w12, w13, w14, and DRw8)-DRB1 gene amplification, the second exon of the DRB1 gene was selectively amplified using each group-specific primer from genomic DNAs of 70 HLA-homozygous B-cell lines and healthy Japanese by PCR. Amplified DNAs were digested with restriction endonucleases and then subjected to electrophoresis assaying simply for cutting, or no cutting, of the DNA, although some alleles can be distinguished only after examination of RFLP band patterns generated and in some cases using double digestion technique with two restriction enzymes. This modified PCR-RFLP method can be successfully applied to all possible DRB1 heterozygotes, despite the fact that 15 pairs of heterozygotes among them cannot be distinguished theoretically by the PCR-SSO method, because the PCR-RFLP method can tell whether two polymorphic sites are linked to each other (cis position) or located on a different chromosome (trans position) by checking the length of RFLP bands generated with double digestion. Thus, the PCR-RFLP method is technically simple, practical and inexpensive for determination of the HLA-DRB1 alleles for routine HLA typing work.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356282     DOI: 10.1111/j.1399-0039.1992.tb01935.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  16 in total

1.  Simultaneous genotyping of DRB1/3/4/5 loci by oligonucleotide microarray.

Authors:  Ye Bang-Ce; Chu Xiaohe; Fan Ye; Li Songyang; Yin Bincheng; Zuo Peng
Journal:  J Mol Diagn       Date:  2005-11       Impact factor: 5.568

2.  Impaired microvascular response to cholinergic stimuli in primary Sjögren's syndrome.

Authors:  L Kovács; T Török; F Bari; Z Kéri; A Kovács; E Makula; G Pokorny
Journal:  Ann Rheum Dis       Date:  2000-01       Impact factor: 19.103

3.  Human CD4+ T lymphocytes recognize a highly conserved epitope of human T lymphotropic virus type 1 (HTLV-1) env gp21 restricted by HLA DRB1*0101.

Authors:  B Kitze; K Usuku; Y Yamano; S Yashiki; M Nakamura; T Fujiyoshi; S Izumo; M Osame; S Sonoda
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

4.  CD4+ and CD8+ clonal T cell expansions indicate a role of antigens in ankylosing spondylitis; a study in HLA-B27+ monozygotic twins.

Authors:  R Duchmann; C Lambert; E May; T Höhler; E Märker-Hermann
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

5.  High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population.

Authors:  Yoshiki Itoh; Nobuhisa Mizuki; Tsuyako Shimada; Fumihiro Azuma; Mitsuo Itakura; Koichi Kashiwase; Eri Kikkawa; Jerzy K Kulski; Masahiro Satake; Hidetoshi Inoko
Journal:  Immunogenetics       Date:  2005-11-08       Impact factor: 2.846

6.  Clinical significance of immunoglobulin G4-associated autoimmune hepatitis.

Authors:  Takeji Umemura; Yoh Zen; Hideaki Hamano; Satoru Joshita; Tetsuya Ichijo; Kaname Yoshizawa; Kendo Kiyosawa; Masao Ota; Shigeyuki Kawa; Yasuni Nakanuma; Eiji Tanaka
Journal:  J Gastroenterol       Date:  2010-09-23       Impact factor: 7.527

7.  Neutralization of transforming growth factor beta 1 augments hepatitis C virus-specific cytotoxic T lymphocyte induction in vitro.

Authors:  T Kanto; T Takehara; K Katayama; A Ito; K Mochizuki; N Kuzushita; T Tatsumi; Y Sasaki; A Kasahara; N Hayashi; M Hori
Journal:  J Clin Immunol       Date:  1997-11       Impact factor: 8.317

8.  The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma).

Authors:  M Kuwana; J Kaburaki; Y Okano; H Inoko; K Tsuji
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

9.  Association of HLA-DR14 with the treatment response in Japanese patients with autoimmune hepatitis.

Authors:  Yoshiyuki Suzuki; Kenji Ikeda; Miharu Hirakawa; Yusuke Kawamura; Hiromi Yatsuji; Hitomi Sezaki; Tetsuya Hosaka; Norio Akuta; Masahiro Kobayashi; Fumitaka Suzuki; Satoshi Saitoh; Yasuji Arase; Mariko Kobayashi; Yuzo Miyakawa; Hiromitsu Kumada
Journal:  Dig Dis Sci       Date:  2010-01-22       Impact factor: 3.199

10.  HLA-DRB1*1502 allele, subtype of DR15, is associated with susceptibility to ulcerative colitis and its progression.

Authors:  S Futami; N Aoyama; Y Honsako; T Tamura; S Morimoto; T Nakashima; A Ohmoto; H Okano; M Miyamoto; H Inaba
Journal:  Dig Dis Sci       Date:  1995-04       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.